Setterwalls advises Recipharm AB (publ) in connection with a rights issue amounting to SEK 805 million
Setterwalls has advised Recipharm AB (publ) in connection with a new share issue with preferential right for the company's shareholders which after the end of the subscription period on 7 June 2016 has been fully subscribed.